Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29 CRS Q1 2026 Earnings EPS Beats Estimates by 408 Stock Shows Modest Uptick SION Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline ALNT Q1 2026 Earnings EPS Misses Estimates Stock Rallies 1255 Azitra Q1 2026 Earnings Significant EPS Miss Amid Development Stage Operations EXAS Q4 2025 Earnings Significant EPS Miss Raises Questions on Path to Profitability